PT-2385 Uses, Dosage, Side Effects and more
PT-2385 is under investigation in clinical trial NCT03108066 (PT2385 for the Treatment of Von Hippel-lindau Disease-associated Clear Cell Renal Cell Carcinoma).
Trade Name | PT-2385 |
Generic | PT-2385 |
Type | |
Formula | C17H12F3NO4S |
Weight | Average: 383.34 Monoisotopic: 383.043913533 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |